What Happened to the Trump Backed Start-up to Make Drugs in US?

Pretomanid tablet, pictured, is a new drug developed by the non-profit TB Alliance for the treatment of highly drug-resistant forms of tuberculosis as part of a combination therapy.

INTERVIEW ON THE PRICE OF BUSINESS SHOW, MEDIA PARTNER OF THIS SITE.

Recently Kevin Price, Host of the nationally syndicated Price of Business Show, interviewed Christopher Rowland.

On a recent Price of Business show, Host Kevin Price interviewed Christopher Rowland of the Washington Post.  Located in Washington, DC, Rowland focuses on the health-care economy’s effects on patient health, costs, and privacy.
Education: University of Arizona, BS in Journalism
According to the Post, “Chris Rowland reports on the business of health care for The Washington Post, which he joined in November 2018. He began his career at the Brattleboro Reformer, a small newspaper in southern Vermont, and remained focused on New England in subsequent posts at the Providence Journal and the Boston Globe. He developed expertise in government accountability coverage, the intersection of business and politics, and health care. Rowland became an editor in 2007 and oversaw the Globe’s coverage of the Massachusetts State House and Boston City Hall. In 2009, he moved to Washington to lead the Globe.”

LISTEN TO THE INTERVIEW IN ITS ENTIRETY HERE:

The Price of Business is one of the longest running shows of its kind in the country and is in markets coast to coast. The Host, Kevin Price, is a multi-award winning author, broadcast journalist, and syndicated columnist. Learn more about the show and its digital partners at www.PriceofBusiness.com (scroll down to the bottom of the page).

Leave a Reply

Your email address will not be published.

RSS
Follow by Email
YouTube
YouTube
LinkedIn
LinkedIn
Share